20 related articles for article (PubMed ID: 8275032)
1. Noninfectious pulmonary complications of haematopoietic stem cell transplantation.
Haider S; Durairajan N; Soubani AO
Eur Respir Rev; 2020 Jun; 29(156):. PubMed ID: 32581138
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 as Biomarker for Acute GvHD and Survival After Allogeneic Transplant With Post-transplant Cyclophosphamide.
Greco R; Lorentino F; Nitti R; Lupo Stanghellini MT; Giglio F; Clerici D; Xue E; Lazzari L; Piemontese S; Mastaglio S; Assanelli A; Marktel S; Corti C; Bernardi M; Ciceri F; Peccatori J
Front Immunol; 2019; 10():2319. PubMed ID: 31632401
[No Abstract] [Full Text] [Related]
3. Interleukin-6 in Allogeneic Stem Cell Transplantation: Its Possible Importance for Immunoregulation and As a Therapeutic Target.
Tvedt THA; Ersvaer E; Tveita AA; Bruserud Ø
Front Immunol; 2017; 8():667. PubMed ID: 28642760
[TBL] [Abstract][Full Text] [Related]
4. Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview.
Blijlevens NM; Donnelly JP; De Pauw BE
Bone Marrow Transplant; 2000 Jun; 25(12):1269-78. PubMed ID: 10871732
[TBL] [Abstract][Full Text] [Related]
5. Soluble tumor necrosis factor (sTNF) receptors: a possible prognostic marker for bone marrow transplantation-related complications.
Or R; Kalinkovich A; Nagler A; Weisman Z; Naparstek E; Weiss L; Hahn T
Cytokines Mol Ther; 1996 Dec; 2(4):243-50. PubMed ID: 9384711
[TBL] [Abstract][Full Text] [Related]
6. IL-6 and IL-8 levels in plasma during hematopoietic progenitor transplantation.
Ferrà C; de Sanjosé S; Gallardo D; Berlanga JJ; Rueda F; Marìn D; de la Banda E; Ancìn I; Peris J; Garcìa J; Grañena A
Haematologica; 1998 Dec; 83(12):1082-7. PubMed ID: 9949625
[TBL] [Abstract][Full Text] [Related]
7. Serum cytokine levels in bone marrow transplantation: synergistic interaction of interleukin-6, interferon-gamma, and tumor necrosis factor-alpha in graft-versus-host disease.
Imamura M; Hashino S; Kobayashi H; Kubayashi S; Hirano S; Minagawa T; Tanaka J; Fujii Y; Kobayashi M; Kasai M
Bone Marrow Transplant; 1994 Jun; 13(6):745-51. PubMed ID: 7920309
[TBL] [Abstract][Full Text] [Related]
8. Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation.
Schots R; Kaufman L; Van Riet I; Ben Othman T; De Waele M; Van Camp B; Demanet C
Leukemia; 2003 Jun; 17(6):1150-6. PubMed ID: 12764383
[TBL] [Abstract][Full Text] [Related]
9. Levels of soluble low affinity IL2 receptors (s-IL2 R) and TNF in the serum after BMT.
Alessandrino EP; Bernasconi P; Colombo A; Boni M; Bonfichi M; Caldera D; Bernasconi C
Bone Marrow Transplant; 1991; 7 Suppl 2():51. PubMed ID: 1878716
[No Abstract] [Full Text] [Related]
10. Lymphokines and the acute-phase response in clinical bone marrow transplantation.
Cohen J; Bayston K
Eur Cytokine Netw; 1990; 1(4):251-5. PubMed ID: 1716489
[TBL] [Abstract][Full Text] [Related]
11. Serum cytokine levels in patients undergoing bone marrow transplantation.
Chasty RC; Lamb WR; Gallati H; Roberts TE; Brenchley PE; Yin JA
Bone Marrow Transplant; 1993 Oct; 12(4):331-6. PubMed ID: 8275032
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
